Innovation

Female scientist in goggles looking at high tech computer screen

Fostering an Ecosystem of Innovation: Using AI to Accelerate Drug Discovery at BMS Cambridge Crossing

Building Careers /

“Innovating in the AI machine learning space to make a faster impact on patients’ lives.” That’s how Thomas Struble, Senior Principal Scientist, Computational Sciences, summarizes the focus of his work at BMS. He and Isha Verma, Principal Scientist, Cheminformatics, are both members of the New Leads in Computational Science team at our Cambridge Crossing site in Cambridge, Massachusetts, which is accelerating small molecule drug discovery using AI capabilities. Learn about the exciting work these two scientists are doing in this rapidly evolving field, and the career possibilities BMS offers for professionals with science and technology skills to turn cutting-edge research into real-world impact. From Computer Science to Cheminformatics As an […]

Fostering an Ecosystem of Innovation: Using AI to Accelerate Drug Discovery at BMS Cambridge Crossing Read More »

“Innovating in the AI machine learning space to make a faster impact on patients’ lives.” That’s how Thomas Struble, Senior Principal Scientist, Computational Sciences, summarizes the focus of his work at BMS. He and Isha Verma, Principal Scientist, Cheminformatics, are both members of the New Leads in Computational Science team at our Cambridge Crossing site in Cambridge, Massachusetts, which is accelerating small molecule drug discovery using AI capabilities. Learn about the exciting work these two scientists are doing in this rapidly evolving field, and the career possibilities BMS offers for professionals with science and technology skills to turn cutting-edge research into real-world impact. From Computer Science to Cheminformatics As an

BMS employee, Ajlan Atasoy, MD

Learn Why Two Science Leaders Who Left BMS Were Inspired to Return

Building Careers /

Delivering groundbreaking treatments and doing transformative work. That’s what motivated two scientists who had worked for BMS to return after pursuing opportunities outside of the organization. Hear what motivated Ajlan Atasoy, MD, Clinical Development Lead, Senior Director, Oncology, and Glenda Trujillo, PhD, Senior Director, Worldwide Medical Immunology and Neuroscience, Pulmonary Fibrosis, to make the return trip to BMS, and continue to do the most interesting, meaningful work of their careers. Inspired by the Innovation and Enthusiasm at BMS For Glenda, earning a PhD in molecular and cell biology was the start of what has become a career devoted to researching hard-to-treat illnesses. Having worked in pathology labs as well as

Learn Why Two Science Leaders Who Left BMS Were Inspired to Return Read More »

Delivering groundbreaking treatments and doing transformative work. That’s what motivated two scientists who had worked for BMS to return after pursuing opportunities outside of the organization. Hear what motivated Ajlan Atasoy, MD, Clinical Development Lead, Senior Director, Oncology, and Glenda Trujillo, PhD, Senior Director, Worldwide Medical Immunology and Neuroscience, Pulmonary Fibrosis, to make the return trip to BMS, and continue to do the most interesting, meaningful work of their careers. Inspired by the Innovation and Enthusiasm at BMS For Glenda, earning a PhD in molecular and cell biology was the start of what has become a career devoted to researching hard-to-treat illnesses. Having worked in pathology labs as well as

Two employees sitting on a bench outside eating lunch

CLIMB Members Discuss Purpose, Growth and Belonging at BMS (video)

Life At BMS /

Belonging. At BMS, it’s a powerful force that allows each of us – no matter our level of experience, age or location – to contribute to our mission. And it’s this very sense of belonging that sparked the creation of CLIMB (Cultivating Leadership and Innovation & Multigenerational Belonging), one of our most dynamic People & Business Resource Groups (PBRGs). Across the globe, CLIMB drives our mission forward by focusing on talent development, connectivity and innovation across all generations within our workforce. Two members of CLIMB shared recently how this community promotes leadership development, professional and personal growth, and a greater sense of fulfillment. Tom Wells, Senior Director, Procurement, and Maggie

CLIMB Members Discuss Purpose, Growth and Belonging at BMS (video) Read More »

Belonging. At BMS, it’s a powerful force that allows each of us – no matter our level of experience, age or location – to contribute to our mission. And it’s this very sense of belonging that sparked the creation of CLIMB (Cultivating Leadership and Innovation & Multigenerational Belonging), one of our most dynamic People & Business Resource Groups (PBRGs). Across the globe, CLIMB drives our mission forward by focusing on talent development, connectivity and innovation across all generations within our workforce. Two members of CLIMB shared recently how this community promotes leadership development, professional and personal growth, and a greater sense of fulfillment. Tom Wells, Senior Director, Procurement, and Maggie

Transforming Careers: AI-driven Tools That Support Our People

Building Careers /

In today’s rapidly evolving workplace, the exponential growth of artificial intelligence (AI) is offering Bristol Myers Squibb more capabilities than ever to hire the right people for the right jobs with the right skills. Internal employees are receiving AI-driven recommendations for projects, stretch assignments, learning, and new job openings across the company – each of which can offer transformational opportunities to learn, grow, and lead. Similarly, AI is empowering recruiters to seek out candidates who have the highest potential for success. Read on to hear from two BMS leaders who are guiding this work. Skills development that empowers employees In a recent podcast, The New Talent Code, Melissa Keiser, Executive Director

Transforming Careers: AI-driven Tools That Support Our People Read More »

In today’s rapidly evolving workplace, the exponential growth of artificial intelligence (AI) is offering Bristol Myers Squibb more capabilities than ever to hire the right people for the right jobs with the right skills. Internal employees are receiving AI-driven recommendations for projects, stretch assignments, learning, and new job openings across the company – each of which can offer transformational opportunities to learn, grow, and lead. Similarly, AI is empowering recruiters to seek out candidates who have the highest potential for success. Read on to hear from two BMS leaders who are guiding this work. Skills development that empowers employees In a recent podcast, The New Talent Code, Melissa Keiser, Executive Director

BMS female scientist in the lab holding a petri dish

A Story of Hope for Patients and Rewarding Career Opportunities in Neuroscience

Building Careers /

How does a fascination with medicine and the human brain evolve into a career? For Ken Kramer, Vice President and Head of Medical Affairs, Neuropsychiatry Therapeutic Area at BMS, it comes down to one word: commitment. Ever since college, Ken has viewed the human brain as distinctly individualized, “the essence of what a person is and who they are.” This viewpoint drew him to work in neuroscience and psychiatry, and to a career in medical affairs—one that has spanned decades and taken him to some of the most prominent and respected global pharmaceutical companies. Having recently welcomed Karuna Therapeutics into our organization, we are fortunate to have Ken join us

A Story of Hope for Patients and Rewarding Career Opportunities in Neuroscience Read More »

How does a fascination with medicine and the human brain evolve into a career? For Ken Kramer, Vice President and Head of Medical Affairs, Neuropsychiatry Therapeutic Area at BMS, it comes down to one word: commitment. Ever since college, Ken has viewed the human brain as distinctly individualized, “the essence of what a person is and who they are.” This viewpoint drew him to work in neuroscience and psychiatry, and to a career in medical affairs—one that has spanned decades and taken him to some of the most prominent and respected global pharmaceutical companies. Having recently welcomed Karuna Therapeutics into our organization, we are fortunate to have Ken join us

BMS Drug Development leader, Nataraj Kalyanaraman, in a dark blazer and wearing glasses

A Leader’s Career Journey Comes Full Circle to Drug Development in BMS Hyderabad

Building Careers /

At BMS, our people directly reflect the strength of our global footprint. Such is the case for Nataraj Kalyanaraman, who joined BMS in 2017. Nataraj began his BMS journey in the U.S., working on the Research and Development (R&D) strategy team in New Jersey. In 2022 he relocated to Lausanne, Switzerland to expand our drug development capabilities. Not only did he achieve this goal, Nataraj grew the organization, setting a strong foundation for drug development in Europe. Now, Nataraj has come full circle to his homeland of India as Vice President, Head of BMS Hyderabad for Global Drug Development. In July 2023, he opened the doors to Drug Development at

A Leader’s Career Journey Comes Full Circle to Drug Development in BMS Hyderabad Read More »

At BMS, our people directly reflect the strength of our global footprint. Such is the case for Nataraj Kalyanaraman, who joined BMS in 2017. Nataraj began his BMS journey in the U.S., working on the Research and Development (R&D) strategy team in New Jersey. In 2022 he relocated to Lausanne, Switzerland to expand our drug development capabilities. Not only did he achieve this goal, Nataraj grew the organization, setting a strong foundation for drug development in Europe. Now, Nataraj has come full circle to his homeland of India as Vice President, Head of BMS Hyderabad for Global Drug Development. In July 2023, he opened the doors to Drug Development at

BMS woman employee and man employee sitting around conference room table collaborating.

Data Science and AI Roles Change the Healthcare Horizon at BMS

Building Careers /

Bristol Myers Squibb is at the forefront of helping patients prevail over serious diseases through our diverse pipeline and new scientific platforms. Some of those ever-evolving and leading-edge platforms involve data science and AI predictive solutions — providing incredibly interesting work along with career growth opportunities. Business Insights & Analytics (BIA) leader, Mike Sobotka, is promoting these careers as they become more crucial to the BMS mission, and more appealing to qualified candidates who might not have previously considered a career in biopharma. As Senior Director and head of Commercialization Data Science and AI Predictive Science, Mike and his team have a number of data science and AI roles available

Data Science and AI Roles Change the Healthcare Horizon at BMS Read More »

Bristol Myers Squibb is at the forefront of helping patients prevail over serious diseases through our diverse pipeline and new scientific platforms. Some of those ever-evolving and leading-edge platforms involve data science and AI predictive solutions — providing incredibly interesting work along with career growth opportunities. Business Insights & Analytics (BIA) leader, Mike Sobotka, is promoting these careers as they become more crucial to the BMS mission, and more appealing to qualified candidates who might not have previously considered a career in biopharma. As Senior Director and head of Commercialization Data Science and AI Predictive Science, Mike and his team have a number of data science and AI roles available

Photo of Milan, BMS employee

Work with a Mission: Cell Therapy Scientist and Manager on Pursuing One’s Passions

Building Careers /

They may be situated on opposite sides of the country, but senior scientist Milan Patel in Seattle, WA, and senior manager Bobby Hewlett in Devens, MA, are of one mind when it comes to the dedication and passion they bring to their careers within Bristol Myers Squibb’s Cell Therapy division. Had You Considered a Career in Commercial Pharma During Your Academic Career?   Both spent much of their graduate education thinking that their future would continue in academic research. After working on PhD projects focused on early research, Milan found a different level of satisfaction in projects that focused on patient treatments. “I realized it was more fulfilling to do

Work with a Mission: Cell Therapy Scientist and Manager on Pursuing One’s Passions Read More »

They may be situated on opposite sides of the country, but senior scientist Milan Patel in Seattle, WA, and senior manager Bobby Hewlett in Devens, MA, are of one mind when it comes to the dedication and passion they bring to their careers within Bristol Myers Squibb’s Cell Therapy division. Had You Considered a Career in Commercial Pharma During Your Academic Career?   Both spent much of their graduate education thinking that their future would continue in academic research. After working on PhD projects focused on early research, Milan found a different level of satisfaction in projects that focused on patient treatments. “I realized it was more fulfilling to do

IT Careers

Accelerating the Science Through IT — Jim Hanly and Beth Basham

Meet Our People /

Across the board, it seems everything is tech, and tech is in everything. That is certainly the case in biopharma, where the rapid pace of technological change is often in lockstep with scientific breakthroughs. It’s one of the few industries where one field so strongly complements and impacts the other. Biopharma and technology are at a pivotal moment and poised to become even more integrated in years to come, requiring uniquely dedicated IT professionals like Jim Hanly and Beth Basham. These BMS colleagues, both experts in their respective IT roles, understand — and are excited by — how technology can best serve the science that provides life-changing medicines to patients.

Accelerating the Science Through IT — Jim Hanly and Beth Basham Read More »

Across the board, it seems everything is tech, and tech is in everything. That is certainly the case in biopharma, where the rapid pace of technological change is often in lockstep with scientific breakthroughs. It’s one of the few industries where one field so strongly complements and impacts the other. Biopharma and technology are at a pivotal moment and poised to become even more integrated in years to come, requiring uniquely dedicated IT professionals like Jim Hanly and Beth Basham. These BMS colleagues, both experts in their respective IT roles, understand — and are excited by — how technology can best serve the science that provides life-changing medicines to patients.

Shawn He and Team Introduce New Cancer Therapies to China

Meet Our People /

Shawn He, Senior Director of Hematology Clinical Research for Bristol Myers Squibb, has always had a passion for helping people. That’s what inspired him to begin his career practicing medicine—working as a clinical physician in his home country of China, where he specialized in helping patients who struggled with rare blood cancers such as chronic myelogenous leukemia. But Shawn quickly came to realize that an opportunity existed for him to help even more people than just the patients he treated one-on-one. That realization began a journey that would eventually lead him to joining Bristol Myers Squibb – a decision he’d make not just once, but twice in his career –

Shawn He and Team Introduce New Cancer Therapies to China Read More »

Shawn He, Senior Director of Hematology Clinical Research for Bristol Myers Squibb, has always had a passion for helping people. That’s what inspired him to begin his career practicing medicine—working as a clinical physician in his home country of China, where he specialized in helping patients who struggled with rare blood cancers such as chronic myelogenous leukemia. But Shawn quickly came to realize that an opportunity existed for him to help even more people than just the patients he treated one-on-one. That realization began a journey that would eventually lead him to joining Bristol Myers Squibb – a decision he’d make not just once, but twice in his career –

Transforming Oncology Markets and Evolving a Career: Anna Shen’s Story

Meet Our People /

Anna Shen is a prime example of the diverse career paths and growth opportunities available throughout BMS globally. Based out of Shanghai, China, Anna is currently an Immuno-Oncology Gastric Cancer Marketing Lead, but the journey from her undergrad and graduate degrees in the UK to exactly what her current role entails, is both eye-opening and fascinating for anyone interested in the sciences. “I graduated with an MS in Pharmacology from Oxford University,” she explained. At that point, Anna found herself at a crossroads, albeit a good one from her perspective. “I had the option of going back to academia for a PhD, or going out into the working world,” she

Transforming Oncology Markets and Evolving a Career: Anna Shen’s Story Read More »

Anna Shen is a prime example of the diverse career paths and growth opportunities available throughout BMS globally. Based out of Shanghai, China, Anna is currently an Immuno-Oncology Gastric Cancer Marketing Lead, but the journey from her undergrad and graduate degrees in the UK to exactly what her current role entails, is both eye-opening and fascinating for anyone interested in the sciences. “I graduated with an MS in Pharmacology from Oxford University,” she explained. At that point, Anna found herself at a crossroads, albeit a good one from her perspective. “I had the option of going back to academia for a PhD, or going out into the working world,” she

Photo of two colleagues working in cell therapy

Battling Cancer Around the Clock with Cell Therapy and Amelia Gutierrez

Meet Our People /

Amelia Gutierrez Perez was just 14 when she knew what she wanted to do for a living–work in bioscience and battle cancer. She had just lost her best friend to the disease, and the passing of her friend sparked a fire inside her that still burns to this day. Now, as a Scientist in BMS’ Quality Control Analytical Testing Group, Amelia works with CAR T technology to help fight cancer on a molecular level. “BMS is leading the way in CAR T cell therapy,” Amelia explains. “It’s an amazing process, because you are using the patient’s own cells. Yes, you can actually manufacture a cancer therapy based on a patient’s

Battling Cancer Around the Clock with Cell Therapy and Amelia Gutierrez Read More »

Amelia Gutierrez Perez was just 14 when she knew what she wanted to do for a living–work in bioscience and battle cancer. She had just lost her best friend to the disease, and the passing of her friend sparked a fire inside her that still burns to this day. Now, as a Scientist in BMS’ Quality Control Analytical Testing Group, Amelia works with CAR T technology to help fight cancer on a molecular level. “BMS is leading the way in CAR T cell therapy,” Amelia explains. “It’s an amazing process, because you are using the patient’s own cells. Yes, you can actually manufacture a cancer therapy based on a patient’s